Phase 2B COPD Trial to Use Point-of-Care Test for Rhinovirus Detection
The phase 2B trial of vapendavir will use bioMérieux’s Biofire Spotfire panel—a CLIA-waived molecular test that detects rhinovirus—to confirm infections in COPD patients.
The phase 2B trial of vapendavir will use bioMérieux’s Biofire Spotfire panel—a CLIA-waived molecular test that detects rhinovirus—to confirm infections in COPD patients.
Hilab showcased its point-of-care Hemogram device capable of delivering a complete blood count with the assistance of artificial intelligence.
Bacterial vaginosis and trichomoniasis results in a range of health complications. A test-and-treat approach can improve diagnosis.
Cue Health has made a de novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue Flu Molecular Test.
Read MoreThe ViroKey SARS-CoV-2 RT-PCR Test v2.0 has the additional capability to be used for pooling, using a three-in-one media pooling strategy.
Read MoreResearchers have developed an accurate rapid test for viruses that can deliver lab-quality test results within 30 minutes.
Read MoreGS Labs offers rapid antigen tests, PCR tests, Rapid PCR and LAMP tests, and a combination rapid antigen COVID and flu tests.
Read MoreA new method has obtained a sensitivity of 100% and a specificity of 87.5% in the detection of SARS-CoV-2 in nasopharyngeal exudate from symptomatic people.
Read MoreResearchers developed a prototype, handheld “breathalyzer” that can sensitively and accurately diagnose COVID-19 in less than 5 minutes.
Read MoreBoston-based Northeastern University fully reopened in Fall 2021 thanks to a rigorous COVID testing program and an in-house laboratory.
Read MorePresident Joe Biden outlined a new plan to combat the surging Omicron variant, including a plan to deploy millions of at-home tests.
Read MoreA new study on rapid COVID-19 testing is investigating whether a saliva-based rapid antigen testing is more effective than the more common PCR tests.
Read MoreThe FDA reissued the EUA for the BinaxNOW COVID-19 Antigen Self Test as a single test without a prescription for people with COVID-19 symptoms.
Read MoreThe FDA has issued an EUA for the SPERA COVID-19 Ag Test, a rapid lateral flow immunoassay from Xtrava Health designed for use at the point of care.
Read MoreLumiraDx announced that the intended use for its FDA EUA-authorized SARS-CoV-2 Antigen Test has been expanded to include asymptomatic individuals.
Read MoreMaking diagnostic tests for SARS-CoV-2 faster or more available could reduce reliance on costly interventions, such as distancing and shutdowns.
Read MoreDotz Nano will introduce its Mega-Diagnostic Platform for en masse, rapid diagnosis of COVID-19 at the point of care.
Read MoreShipments are now available for the BD Veritor At-Home COVID-19 Test, an over-the-counter COVID-19 rapid antigen test.
Read More